Artificial intelligence is no longer a side conversation in gastroenterology.
It is moving to the center of operations — and future competitive advantage.
In this episode of The Scope Forward Show, I sit down with Dr. Michael Dragutsky (Chairman, One GI), Christa Newton (CEO, One GI), Aniket Behera (COO and Co-founder, 100ms), and Satish Malnaik (CEO, NextServices).
We go inside One GI’s AI strategy — not to debate AI — but to examine what happens when a PE-funded scaled GI platform treats AI as a leadership decision.
This is not about implementing AI in the endoscopy room.
It’s not about bounding boxes in CADe or CADx.
AI is about the business model of gastroenterology.
A multi-decade real decline in colonoscopy reimbursement. Rising labor costs. Staffing shortages. Payers deploying AI to protect their margins. A move toward non-invasive tests.
AI will not disrupt GI because it’ll outperform physicians. It will disrupt GI because the dynamics of the business of healthcare is shifting rapidly. That changes cost structures, leverage, and speed.
Those who can keep up will survive and thrive through the next decade.
Inside this conversation:
- Why AI infrastructure is compounding faster than Moore’s Law
- Where AI is reliable today — and where it is not
- Why the first real battleground is administrative — not clinical
- How One GI chose where to begin — and why sequencing matters
- The shift from task automation to agentic systems executing full workflows
- Whether AI will outperform physicians in defined domains — and what that means for training and governance
As I’ve been saying since the publishing of The Shift. The change is not ahead of us. The future is here and now.
Whether it’s for your career or practice, take the time to watch this episode in full. It’s loaded with practical insights.